Alejandro Dorenbaum
Direttore Tecnico/Scientifico/R&S presso RENEO PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Alejandro Dorenbaum
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - | - |
Storia della carriera di Alejandro Dorenbaum
Precedenti posizioni note di Alejandro Dorenbaum
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALLAKOS INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2014 | 01/06/2017 |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/02/2013 | 30/06/2014 |
| BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2009 | 01/01/2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2003 | 01/01/2003 |
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/2000 | 01/01/2000 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 | - |
Formazione di Alejandro Dorenbaum
| Universidad Nacional Autónoma de México | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Messico | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ALLAKOS INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Lumena Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Alejandro Dorenbaum
- Esperienza
